ASHP InterSections ASHP InterSections

May 26, 2016

ASHP Building Update (May 2016)

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

IT IS MY PLEASURE to announce that ASHP has sold our headquarters building at 7272 Wisconsin Avenue in Bethesda, Md., and will be moving to a wonderful new building just a few blocks away early next year.

ASHP has been in our current headquarters — The Joseph A. Oddis Building — since we purchased it in 1992. Since that time, ASHP has grown dramatically, and so has downtown Bethesda. It’s because of this growth and change that we decided to sell our building.

For some time now, the state of Maryland and surrounding counties have envisioned a new east-west train line that would better connect commuters and visitors to key parts of the Washington, D.C., metro area, including Bethesda. After many years, the funding for this new Purple Line is now secured, and building on the new line is projected to start in the next few years. ASHP fits into this story because our current building in the heart of downtown Bethesda sits on the location of the proposed new Metro Purple Line Station, on a piece of real estate that is ripe for a major new downtown development.

The Joseph A. Oddis Building

The Joseph A. Oddis Building

Because of the decision to sell our building, ASHP will be able to move into a new headquarters that is modern and environmentally friendly, a headquarters that will accommodate our growing membership and staff, provide enhanced capabilities and resources to help us better serve our members, and advance our public health mission.

Our space in this new building is currently being constructed, and I look forward to sharing some images with you once it’s completed. I also welcome you to come tour our new space if you’re ever in town visiting or serving on an ASHP member committee. ASHP is your professional home, and we would love to see you!

I would like to recognize my predecessor, Dr. Joseph A. Oddis, for his vision and subsequent decision to purchase the ASHP building well before Bethesda experienced such explosive growth. It’s fair to say that, without him, ASHP would not be in the position it is today as the best and fastest growing pharmacy organization in the world.

ASHP's new headquarters building

ASHP’s new headquarters building

I hope that you share our excitement as we move to ASHP’s new home. Most importantly, I want to thank all of you — our members — for everything that you do for your patients and the profession. It’s because of you that ASHP continues to grow and excel. I look forward to updating you in the coming months about our forthcoming move to our new headquarters, and continuing to share updates on the exceptional resources ASHP provides to advance your practice.

Have a wonderful day, and thank you so much for being a member of ASHP!

Sincerely,

Paul

November 19, 2015

Update on the Joseph A. Oddis Building: November 2015

Filed under: Current Issue,From the CEO — Tags: , , , — jmilford @ 2:05 pm
Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

A LITTLE OVER A YEAR AGO, I shared with you that ASHP was exploring the option of selling our current headquarters building and relocating to state-of-the-art offices. In that blog, I noted that ASHP had been approached by Montgomery County, Maryland, (where ASHP is located) to explore the Society’s willingness to consider a sale of our building to accommodate the county’s plans for construction of a transit station.

ASHP’s consideration for selling our building centers on one thing: our members. Because ASHP is a not-for-profit professional society dedicated to advancing healthcare and pharmacy practice, any consideration for selling our building must put ASHP in a position to continue providing the high level of service that our members deserve. Further, it must ensure that ASHP remains financially strong long into the future in order to support the Society’s robust public health and membership mission.

After consultation with legal experts and the ASHP Board of Directors, we made the decision to move forward with marketing the building for sale, and have selected a purchaser for the possible sale of our property. We are currently in the process of working with that purchaser on the legal terms that would ultimately guide a transaction. We have also identified and are actively engaged in negotiations for new office space. Should ASHP sell our building and relocate, we would remain in downtown Bethesda, where we have been an active part of the community for nearly 50 years. We would also move into modern offices that would better facilitate member and stakeholder engagement, with continued easy access to public transportation, hotels, and restaurants.

The negotiations continue to move forward. While we are optimistic that we will reach an agreement that will serve the interests of ASHP’s members, a final determination will not be made until a due diligence period is concluded. Once a firm decision has been reached, I will provide you with an update on our future plans.

Thank you for your continued support of ASHP, and for everything that you do for your patients.

Sincerely,

Paul

February 11, 2013

ASHP Headquarters Named to Honor Dr. Joseph A. Oddis

Filed under: From the CEO,Home — Tags: , , , — jmilford @ 10:30 am

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

TODAY, I AM PLEASED TO MAKE a very special announcement to the members of ASHP.

At its January meeting, the Board of Directors voted unanimously to name the ASHP headquarters building, here at 7272 Wisconsin Avenue in Bethesda, Md., after the man who led our organization for 37 years: Dr. Joseph A. Oddis.

As of now, the headquarters of ASHP will be known as the Joseph A. Oddis Building. The building will be dedicated at a ceremony to be held this spring.

There could not be a more fitting person to receive this honor. Dr. Oddis’ leadership over nearly four decades helped make ASHP the strong, vibrant, growing, and influential organization it is today. Joe’s vision for what ASHP could be and the important role we could play in shaping pharmacy practice, improving patient care, and influencing public policy to improve public health set this organization on the path it still follows today.

Here are just a few significant achievements from Dr. Oddis’ career and his legacy to ASHP:

  • Joined ASHP in 1960 as Executive Secretary, later to be renamed Chief Executive Officer.
  • Leading ASHP’s growth from 3300 members and a staff of 1 (himself!) to 31,000 members and a staff of 180.
  • Developing a staff culture that focuses on serving our members in a respectful, team-based approach, with a commitment to excellence.
  • Growing ASHP’s education services, launching the national meetings that would become the ASHP Summer Meeting and the ASHP Midyear Clinical Meeting, now the largest meeting of pharmacists in the world.
  • Building upon ASHP’s early support of international efforts to improve pharmacy practice, including serving as president of FIP from 1986 – 1990.
  • Improving pharmacy practice and raising the visibility and status of ASHP by recognizing the importance of practice standards. Under Dr. Oddis’ stewardship, ASHP worked with practitioners to develop and publish nearly 100 practice standards, guidelines, technical assistance bulletins, and position papers.
  • Helping promote the concept of formularies and the acceptance of pharmacy and therapeutics (P&T) committees in the early 1960s by building consensus among key stakeholders, including the American Hospital Association, the American Medical Association, the American Pharmacists Association, and ASHP.  In 1965, Medicare based its standards on ASHP’s statements and standards and The Joint Commission deemed an active P&T committee essential for hospital accreditation.
  • Establishing ASHP’s pharmacy residency accreditation program, now celebrating its 50th anniversary. Today, ASHP has 1,582 pharmacy residency programs and 246 pharmacy technician training programs in the accreditation process. In 2012, there were more than 2,500 residents in a PGY1 or PGY2 residency program.
  • Creating the ASHP Research and Education Foundation, which today offers extensive research grant, educational, and awards programs that assist and recognize pharmacists providing care to patients in our nation’s hospitals and health systems, leading to optimal medication outcomes.
  •  Expanding ASHP’s publishing efforts:
    • Introducing the American Hospital Formulary Service (AHFS), which has gained national recognition as the most comprehensive resource of unbiased drug information, and recognized by the U.S. Congress as an official compendium.
    • Introducing International Pharmaceutical Abstracts (IPA), which was published by ASHP from 1964 to 2004.
    • 1964 publication of Mirror to Hospital Pharmacy, which has developed into the ASHP National Survey of Hospital and Health-System Practice.
  • Building ASHP’s leadership and influence by collaborating with other pharmacy and health care organizations and government regulatory agencies on the important issues of the time, including the American Hospital Association, the American Nurses Association, the American Society of Internal Medicine, The Joint Commission, the Food and Drug Administration, and the agency that administered Medicare, among others.

Please join me in thanking Dr. Oddis for his dedication to ASHP and the profession of pharmacy.

 

Powered by WordPress